Article(id=1329875922494271846, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329875908023922880, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.12.008, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1710950400000, receivedDateStr=2024-03-21, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794996727822, onlineDateStr=2026-11-18, pubDate=1733760000000, pubDateStr=2024-12-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794996727822, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794996727822, creator=13701087609, updateTime=1794996727822, updator=13701087609, issue=Issue{id=1329875908023922880, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='12', pageStart='1603', pageEnd='1728', issueExtLink='null', onlineDate='null', pubDate='1733760000000', pubDateStr='2024-12-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794996724372, creator='13701087609', updateTime=1794996724372, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext=null, issueFiles=null, downloadFileDto=null}, startPage=1651, endPage=1658, ext={EN=ArticleExt(id=1329875922691404135, articleId=1329875922494271846, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Construction of a Bispecific Antibody Targeting Mesothelin with Anti-tumor Activity via NK Cell Activation, columnId=1322624454216238014, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Paper, runingTitle=null, highlight=null, articleAbstract=

CD16 has the capacity to effectively mediate natural killer(NK) cell activation without the necessity for co-engagement of other receptors, making it a widely selected target in bispecific antibodies(BsAbs) based on NK cell redirection. Mesothelin(MSLN) is significantly overexpressed in various solid tumors and can promote tumor cell adhesion, migration, proliferation, and survival. In this study, a bispecific antibody, 16MSLN, targeting both CD16 and MSLN was constructed. The antibody was expressed in Expi293F cells and purified using Protein L to obtain highly pure target antibody. The results of cell experiments indicated that 16MSLN could promote the crosslinking of NK cells with target cells and specifically enhance the killing effect of NK cells on MSLN+ tumor cells. This study provides a reference for the development of NK cell-redirected BsAbs.

, authors=Cong YU, Jianwei ZHU*, authorsList=Cong YU, Jianwei ZHU, authorCompany=null, correspAuthors=Jianwei ZHU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329875922884342120, articleId=1329875922494271846, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=间皮素靶向的双特异性抗体构建及其介导的NK细胞抗肿瘤作用研究, columnId=1322624454384010176, journalTitle=中国医药工业杂志, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=

CD16分子可以强效介导NK细胞激活而不需要其他受体的共同参与,在基于自然杀伤(NK)细胞重导向的双特异性抗体(BsAbs)中被广泛选择。间皮素(MSLN)在多种实体瘤中显著过度表达,能促进肿瘤细胞的黏附、迁移、增殖和存活。该研究构建了1种靶向CD16和MSLN的双特异性抗体16MSLN,通过Expi293F细胞表达抗体,经Protein L纯化后即能获得高纯度的16MSLN。细胞试验结果显示,16MSLN能促进NK细胞与靶细胞交联,并特异性增强NK细胞对MSLN+肿瘤细胞的杀伤作用。该研究为实体瘤治疗和MSLN靶点药物开发提供了参考。

, authors=余聪, 朱建伟*, authorsList=余聪, 朱建伟, authorCompany=null, correspAuthors=朱建伟, authorNote=

余聪(1999—),男,硕士研究生,专业方向:微生物与生化药学。

, correspAuthorsNote=
朱建伟(1956—),男,博士,讲席教授,从事生物技术药物的研发。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=xvrGeZ6cAdA1EayUYw9/qg==, magXml=qUSnzZb2T2EvHEtVeXTjRA==, pdfUrl=null, pdf=aSuyXiXXf6qd3ME7Qb/MyA==, pdfFileSize=2292792, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=vUXLLnR7R/FEEjF/ObhaIA==, mapNumber=null, fund=null)}, authors=[Author(id=1329875923148583277, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875923228275055, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, authorId=1329875923148583277, language=EN, stringName=Cong YU, firstName=Cong, middleName=null, lastName=YU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Engineering Research Center of Cell & Therapeutic Antibody, MOE, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875923291189616, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, authorId=1329875923148583277, language=CN, stringName=余聪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学药学院,细胞工程及抗体药物教育部工程研究中心,上海 200240, bio={"content":"

余聪(1999—),男,硕士研究生,专业方向:微生物与生化药学。

"}, bioImg=null, bioContent=

余聪(1999—),男,硕士研究生,专业方向:微生物与生化药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875923060502889, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, xref=null, ext=[AuthorCompanyExt(id=1329875923068891498, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, companyId=1329875923060502889, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Engineering Research Center of Cell & Therapeutic Antibody, MOE, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240), AuthorCompanyExt(id=1329875923077280107, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, companyId=1329875923060502889, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学药学院,细胞工程及抗体药物教育部工程研究中心,上海 200240)])]), Author(id=1329875923349909874, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=jianweiz@sjtu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329875923412824436, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, authorId=1329875923349909874, language=EN, stringName=Jianwei ZHU, firstName=Jianwei, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Engineering Research Center of Cell & Therapeutic Antibody, MOE, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875923479933301, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, authorId=1329875923349909874, language=CN, stringName=朱建伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海交通大学药学院,细胞工程及抗体药物教育部工程研究中心,上海 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875923060502889, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, xref=null, ext=[AuthorCompanyExt(id=1329875923068891498, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, companyId=1329875923060502889, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Engineering Research Center of Cell & Therapeutic Antibody, MOE, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240), AuthorCompanyExt(id=1329875923077280107, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, companyId=1329875923060502889, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学药学院,细胞工程及抗体药物教育部工程研究中心,上海 200240)])])], keywords=[Keyword(id=1329875923572207990, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, language=EN, orderNo=1, keyword=bispecific antibody), Keyword(id=1329875923664482679, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, language=EN, orderNo=2, keyword=natural killer cell), Keyword(id=1329875923731591544, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, language=EN, orderNo=3, keyword=mesothelin), Keyword(id=1329875923790311801, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, language=EN, orderNo=4, keyword=CD16), Keyword(id=1329875923849032058, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, language=CN, orderNo=1, keyword=双特异性抗体), Keyword(id=1329875923907752315, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, language=CN, orderNo=2, keyword=NK细胞), Keyword(id=1329875923966472572, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, language=CN, orderNo=3, keyword=间皮素), Keyword(id=1329875924016804221, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, language=CN, orderNo=4, keyword=CD16)], refs=[Reference(id=1329875924100690302, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=SPIESS C, ZHAI Q T, CARTER P J.Alternative molecular formats and therapeutic applications for bispecific antibodies[J].Mol Immunol, 2015, 67(2 Pt A): 95-106., articleTitle=null, refAbstract=null), Reference(id=1329875924163604863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=PAN Z D, CHEN J, XIAO X D, et al.Characterization of a novel bispecific antibody targeting tissue factor-positive tumors with T cell engagement [J].Acta Pharm Sin B, 2022, 12(4): 1928-1942., articleTitle=null, refAbstract=null), Reference(id=1329875924226519424, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN J, PAN Z D, HAN L, et al.A novel bispecific antibody targeting CD3 and Lewis Y with potent therapeutic efficacy against gastric cancer [J].Biomedicines, 2021, 9(8): 1059., articleTitle=null, refAbstract=null), Reference(id=1329875924289433985, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU S J, LIU M G, REN F, et al.The landscape of bispecific T cell engager in cancer treatment [J].Biomarker Res, 2021, 9(1): 38., articleTitle=null, refAbstract=null), Reference(id=1329875924343959938, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=KENNEDY L B, SALAMA A K S.A review of cancer immunotherapy toxicity [J].CA Cancer J Clin, 2020, 70(2): 86-104., articleTitle=null, refAbstract=null), Reference(id=1329875924398485891, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=VIVIER E, RAULET D H, MORETTA A, et al.Innate or adaptive immunity? The example of natural killer cells [J].Science, 2011, 331(6013): 44-49., articleTitle=null, refAbstract=null), Reference(id=1329875924457206148, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=MYERS J A, MILLER J S.Exploring the NK cell platform for cancer immunotherapy [J].Nat Rev Clin Oncol, 2021, 18(2): 85-100., articleTitle=null, refAbstract=null), Reference(id=1329875924511732101, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=BOURNAZOS S, RAVETCH J V.Ravetch, fcgamma receptor function and the design of vaccination strategies [J].Immunity, 2017, 47(2): 224-233., articleTitle=null, refAbstract=null), Reference(id=1329875924570452358, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=VALLERA D A, FERRONE S, KODAL B, et al.NK-cell-mediated targeting of various solid tumors using a B7-H3 tri-specific killer engager in vitro and in vivo [J].Cancers (Basel), 2020, 12(9): 2659., articleTitle=null, refAbstract=null), Reference(id=1329875924620784007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=ARVINDAM U S, VAN HAUTEN P M M, SCHIRM D, et al.A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells[J].Leukemia, 2021, 35(6): 1586-1596., articleTitle=null, refAbstract=null), Reference(id=1329875924675309960, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=SERVAIS E L, COLOVOS C, RODRIGUEZ L, et al.Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients [J].Clin Cancer Res, 2012, 18(9): 2478-2489., articleTitle=null, refAbstract=null), Reference(id=1329875924742418825, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=HAGERTY B L, TAKABE K.Biology of mesothelin and clinical implications: a review of existing literature [J].World J Oncol, 2023, 14(5): 340-349., articleTitle=null, refAbstract=null), Reference(id=1329875924805333386, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=KLAMPATSA A, DIMOU V, ALBELDA S M.Mesothelin-targeted CAR-T cell therapy for solid tumors [J].Expert Opin Biol Ther, 2021, 21(4): 473-486., articleTitle=null, refAbstract=null), Reference(id=1329875924868247947, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=HASSAN R, THOMAS A, ALEWINE C, et al.Mesothelin immunotherapy for cancer: Ready for prime time? [J].J Clin Oncol, 2016, 34(34): 4171-4179., articleTitle=null, refAbstract=null), Reference(id=1329875924926968204, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=CHENG Y, ZHENG X D, WANG X F, et al.Trispecific killer engager 161519 enhances natural killer cell function and provides anti-tumor activity against CD19-positive cancers [J].Cancer Biol Med, 2020, 17(4): 1026-1038., articleTitle=null, refAbstract=null), Reference(id=1329875925002465677, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=REUSING S B, VALLERA D A, MANSER A R, et al.CD16×CD33 bispecific killer cell engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL [J].Cancer Immunol Immunother, 2021, 70(12): 3701-3708., articleTitle=null, refAbstract=null), Reference(id=1329875925073768846, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=REUSCH U, BURKHARDT C, FUCEK I, et al.A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30 tumor cells [J].MABs, 2014, 6(3): 727-738., articleTitle=null, refAbstract=null), Reference(id=1329875925145072015, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=KHADKA R H, SAKEMURA R, KENDERIAN S S, et al.Management of cytokine release syndrome: an update on emerging antigen-specific T cell engaging immunotherapies[J].Immunotherapy, 2019, 11(10): 851-857., articleTitle=null, refAbstract=null), Reference(id=1329875925212180880, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=DEL BANO J, FLORÈS-FLORÈS R, JOSSELIN E, et al.A bispecific antibody-based approach for targeting mesothelin in triple negative breast cancer [J].Front Immunol, 2019, 10: 1593., articleTitle=null, refAbstract=null), Reference(id=1329875925283484049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=SHI W Q, LV L Y, LIU N, et al.A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity [J].Mol Ther, 2023, 31(1): 66-77., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329875923060502889, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, xref=null, ext=[AuthorCompanyExt(id=1329875923068891498, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, companyId=1329875923060502889, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Engineering Research Center of Cell & Therapeutic Antibody, MOE, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240), AuthorCompanyExt(id=1329875923077280107, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, companyId=1329875923060502889, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学药学院,细胞工程及抗体药物教育部工程研究中心,上海 200240)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.12.008, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.12.008, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.12.008, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.12.008, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1733760000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
间皮素靶向的双特异性抗体构建及其介导的NK细胞抗肿瘤作用研究
余聪 , 朱建伟 *
中国医药工业杂志 | 研究论文 2024,55(12): 1651-1658
收起
收藏切换
中国医药工业杂志 |研究论文 2024 , 55 (12) : 1651 -1658
间皮素靶向的双特异性抗体构建及其介导的NK细胞抗肿瘤作用研究
全屏
[Author(id=1329875923148583277, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875923228275055, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, authorId=1329875923148583277, language=EN, stringName=Cong YU, firstName=Cong, middleName=null, lastName=YU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Engineering Research Center of Cell & Therapeutic Antibody, MOE, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875923291189616, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, authorId=1329875923148583277, language=CN, stringName=余聪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学药学院,细胞工程及抗体药物教育部工程研究中心,上海 200240, bio={"content":"

余聪(1999—),男,硕士研究生,专业方向:微生物与生化药学。

"}, bioImg=null, bioContent=

余聪(1999—),男,硕士研究生,专业方向:微生物与生化药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875923060502889, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, xref=null, ext=[AuthorCompanyExt(id=1329875923068891498, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, companyId=1329875923060502889, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Engineering Research Center of Cell & Therapeutic Antibody, MOE, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240), AuthorCompanyExt(id=1329875923077280107, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, companyId=1329875923060502889, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学药学院,细胞工程及抗体药物教育部工程研究中心,上海 200240)])]), Author(id=1329875923349909874, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=jianweiz@sjtu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329875923412824436, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, authorId=1329875923349909874, language=EN, stringName=Jianwei ZHU, firstName=Jianwei, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Engineering Research Center of Cell & Therapeutic Antibody, MOE, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875923479933301, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, authorId=1329875923349909874, language=CN, stringName=朱建伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海交通大学药学院,细胞工程及抗体药物教育部工程研究中心,上海 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875923060502889, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, xref=null, ext=[AuthorCompanyExt(id=1329875923068891498, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, companyId=1329875923060502889, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Engineering Research Center of Cell & Therapeutic Antibody, MOE, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240), AuthorCompanyExt(id=1329875923077280107, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875922494271846, companyId=1329875923060502889, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学药学院,细胞工程及抗体药物教育部工程研究中心,上海 200240)])])]
余聪, 朱建伟*
作者信息
  • 上海交通大学药学院,细胞工程及抗体药物教育部工程研究中心,上海 200240
通讯作者:
朱建伟(1956—),男,博士,讲席教授,从事生物技术药物的研发。E-mail:
作者简介:

余聪(1999—),男,硕士研究生,专业方向:微生物与生化药学。

Construction of a Bispecific Antibody Targeting Mesothelin with Anti-tumor Activity via NK Cell Activation
Cong YU, Jianwei ZHU*
Affiliations
  • Engineering Research Center of Cell & Therapeutic Antibody, MOE, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240
出版时间: 2024-12-10 doi: 10.16522/j.cnki.cjph.2024.12.008
文章导航
收藏切换

CD16分子可以强效介导NK细胞激活而不需要其他受体的共同参与,在基于自然杀伤(NK)细胞重导向的双特异性抗体(BsAbs)中被广泛选择。间皮素(MSLN)在多种实体瘤中显著过度表达,能促进肿瘤细胞的黏附、迁移、增殖和存活。该研究构建了1种靶向CD16和MSLN的双特异性抗体16MSLN,通过Expi293F细胞表达抗体,经Protein L纯化后即能获得高纯度的16MSLN。细胞试验结果显示,16MSLN能促进NK细胞与靶细胞交联,并特异性增强NK细胞对MSLN+肿瘤细胞的杀伤作用。该研究为实体瘤治疗和MSLN靶点药物开发提供了参考。

双特异性抗体  /  NK细胞  /  间皮素  /  CD16

CD16 has the capacity to effectively mediate natural killer(NK) cell activation without the necessity for co-engagement of other receptors, making it a widely selected target in bispecific antibodies(BsAbs) based on NK cell redirection. Mesothelin(MSLN) is significantly overexpressed in various solid tumors and can promote tumor cell adhesion, migration, proliferation, and survival. In this study, a bispecific antibody, 16MSLN, targeting both CD16 and MSLN was constructed. The antibody was expressed in Expi293F cells and purified using Protein L to obtain highly pure target antibody. The results of cell experiments indicated that 16MSLN could promote the crosslinking of NK cells with target cells and specifically enhance the killing effect of NK cells on MSLN+ tumor cells. This study provides a reference for the development of NK cell-redirected BsAbs.

bispecific antibody  /  natural killer cell  /  mesothelin  /  CD16
余聪, 朱建伟. 间皮素靶向的双特异性抗体构建及其介导的NK细胞抗肿瘤作用研究. 中国医药工业杂志, 2024 , 55 (12) : 1651 -1658 . DOI: 10.16522/j.cnki.cjph.2024.12.008
Cong YU, Jianwei ZHU. Construction of a Bispecific Antibody Targeting Mesothelin with Anti-tumor Activity via NK Cell Activation[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (12) : 1651 -1658 . DOI: 10.16522/j.cnki.cjph.2024.12.008

参考文献 引证文献
排序方式:
[1]
SPIESS C, ZHAI Q T, CARTER P J.Alternative molecular formats and therapeutic applications for bispecific antibodies[J].Mol Immunol, 2015, 67(2 Pt A): 95-106.
[2]
PAN Z D, CHEN J, XIAO X D, et al.Characterization of a novel bispecific antibody targeting tissue factor-positive tumors with T cell engagement [J].Acta Pharm Sin B, 2022, 12(4): 1928-1942.
[3]
CHEN J, PAN Z D, HAN L, et al.A novel bispecific antibody targeting CD3 and Lewis Y with potent therapeutic efficacy against gastric cancer [J].Biomedicines, 2021, 9(8): 1059.
[4]
ZHOU S J, LIU M G, REN F, et al.The landscape of bispecific T cell engager in cancer treatment [J].Biomarker Res, 2021, 9(1): 38.
[5]
KENNEDY L B, SALAMA A K S.A review of cancer immunotherapy toxicity [J].CA Cancer J Clin, 2020, 70(2): 86-104.
[6]
VIVIER E, RAULET D H, MORETTA A, et al.Innate or adaptive immunity? The example of natural killer cells [J].Science, 2011, 331(6013): 44-49.
[7]
MYERS J A, MILLER J S.Exploring the NK cell platform for cancer immunotherapy [J].Nat Rev Clin Oncol, 2021, 18(2): 85-100.
[8]
BOURNAZOS S, RAVETCH J V.Ravetch, fcgamma receptor function and the design of vaccination strategies [J].Immunity, 2017, 47(2): 224-233.
[9]
VALLERA D A, FERRONE S, KODAL B, et al.NK-cell-mediated targeting of various solid tumors using a B7-H3 tri-specific killer engager in vitro and in vivo [J].Cancers (Basel), 2020, 12(9): 2659.
[10]
ARVINDAM U S, VAN HAUTEN P M M, SCHIRM D, et al.A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells[J].Leukemia, 2021, 35(6): 1586-1596.
[11]
SERVAIS E L, COLOVOS C, RODRIGUEZ L, et al.Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients [J].Clin Cancer Res, 2012, 18(9): 2478-2489.
[12]
HAGERTY B L, TAKABE K.Biology of mesothelin and clinical implications: a review of existing literature [J].World J Oncol, 2023, 14(5): 340-349.
[13]
KLAMPATSA A, DIMOU V, ALBELDA S M.Mesothelin-targeted CAR-T cell therapy for solid tumors [J].Expert Opin Biol Ther, 2021, 21(4): 473-486.
[14]
HASSAN R, THOMAS A, ALEWINE C, et al.Mesothelin immunotherapy for cancer: Ready for prime time? [J].J Clin Oncol, 2016, 34(34): 4171-4179.
[15]
CHENG Y, ZHENG X D, WANG X F, et al.Trispecific killer engager 161519 enhances natural killer cell function and provides anti-tumor activity against CD19-positive cancers [J].Cancer Biol Med, 2020, 17(4): 1026-1038.
[16]
REUSING S B, VALLERA D A, MANSER A R, et al.CD16×CD33 bispecific killer cell engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL [J].Cancer Immunol Immunother, 2021, 70(12): 3701-3708.
[17]
REUSCH U, BURKHARDT C, FUCEK I, et al.A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30 tumor cells [J].MABs, 2014, 6(3): 727-738.
[18]
KHADKA R H, SAKEMURA R, KENDERIAN S S, et al.Management of cytokine release syndrome: an update on emerging antigen-specific T cell engaging immunotherapies[J].Immunotherapy, 2019, 11(10): 851-857.
[19]
DEL BANO J, FLORÈS-FLORÈS R, JOSSELIN E, et al.A bispecific antibody-based approach for targeting mesothelin in triple negative breast cancer [J].Front Immunol, 2019, 10: 1593.
[20]
SHI W Q, LV L Y, LIU N, et al.A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity [J].Mol Ther, 2023, 31(1): 66-77.
2024年第55卷第12期
35
8
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.12.008
  • 接收时间:2024-03-21
  • 首发时间:2026-11-18
  • 出版时间:2024-12-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-03-21
基金
作者信息
    上海交通大学药学院,细胞工程及抗体药物教育部工程研究中心,上海 200240

通讯作者:

朱建伟(1956—),男,博士,讲席教授,从事生物技术药物的研发。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.12.008
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏